Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Innate defence against tumor cells: the killer cell IKDC].

Bulletin du cancer - 1 May 2006

Chaput Nathalie, Taieb Julien, Zitvogel Laurence

Abstract excerpt

IKDC (IFN-producing killer dendritic cell) is a new and rare subset of dendritic cells recently identified in mice. IKDCs possess both natural killer and dendritic cell markers. They can lyse tumor target cells without prior activation through several different lysis pathways : perforin, TRAIL or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Imatinib Mesylate
Share to Adoptive Transfer
Share to Benzamides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunity, Cellular

Share to Immunologic Surveillance

Share to Interferons

Share to Interleukin-2

Share to Melanoma, Experimental

Source

Identifiers

PMID: 16777622

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16777622-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Innate defence against tumor cells: the killer cell IKDC].PMID 16777622Read ↗

A novel cell subset: interferon-producing killer dendritic cells.Semantic proximity Read ↗

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Semantic proximity Read ↗

<i>Bona fide</i> cytotoxic iNKT cells with superior antitumour responses identified in mice and humansSemantic proximity Read ↗

T-bet transduction enhances anti-tumor efficacy of IFN-producing dendritic cell (IKDC) against hepatocellular carcinoma via apoptosis induction.Semantic proximity Read ↗

Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined TherapiesSemantic proximity Read ↗

iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti–PD-1 therapySemantic proximity Read ↗

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.Semantic proximity Read ↗

Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiationSemantic proximity Read ↗

Inducing antitumor T cell immunity: comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line model.Semantic proximity Read ↗

IL-1R8 : a novel checkpoint regulating anti-tumor and anti-viral activity of NK cellsSemantic proximity Read ↗

DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for ImmunotherapySemantic proximity Read ↗

Novel NK cell-like phenotype expressing CCR5 and its ligands elicits tumor-specific acquired immunity to carcinomatous peritonitis via host NK-derived IFN-γ.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.